Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AVC-201 |
Trade Name | |
Synonyms | AVC 201|AVC201 |
Drug Descriptions |
AVC-201 (Allo-RevCAR01-T-CD123) comprises an allogeneic chimeric antigen receptor (CAR) T-cell therapy containing a universal switchable CAR targeting CD123, which potentially induces killing of tumor cells expressing CD123 (Cancer Res (2023) 83 (7_Supplement): 4095). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AVC-201 | AVC-201 | 0 | 1 |